Schizophrenia.
Freedman
Robert
R
Institute for Children's Mental Disorders, University of Colorado and the Veterans Affairs Medical Center, Denver, USA. robert.freedman@uchsc.edu
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002648:Child; D003024:Clozapine / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D017966:Pyramidal Cells / Q000187:drug effects / Q000503:physiopathology; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D003024:Clozapine; D004298:Dopamine